Norris Medicines MD, chairman, board of directors and AGM
BSE: 524414Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹15.00.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15 Cr4,400th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 0.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 748
Norris Medicines board of directors
At the end of the quarter to Mar 2019, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonVimal Dhirendra Shah
- Company Secretary and Compliance OfficerVINAY RANA
6 directors4 independent1 executive1 non-executive
- Vimal Dhirendra Shah · ChairpersonExecutive · joined Apr 2015 · 1 listed board · 2 committee seats
- Sanjivkumar ShahIndependent · joined Sep 2014 · 60 months as independent · 1 listed board
- Hiten M ParikhIndependent · joined Sep 2015 · 60 months as independent · 1 listed board
- Shaik Amanullah Mohamed AzmathullahIndependent · joined Sep 2018 · 60 months as independent · 1 listed board · 2 committee seats
- Jayanti ChandrasekarIndependent · joined Sep 2018 · 60 months as independent · 1 listed board
- Navnit Jethabhai PatelNon-executive · joined Sep 1990 · 1 listed board
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 27 Mar 201945 days in between
- 9 Feb 201987 days in between
- 13 Nov 2018
Audit Committee
Chair Sanjivkumar Shah
Vimal Dhirendra Shah, Jayanti Chandrasekar
- 9 Feb 201987 days in between
Nomination and remuneration committee
Chair Sanjivkumar Shah
Navnit Jethabhai Patel, Shaik Amanullah Mohamed Azmathullah, Hiten M Parikh
1 meeting of 1 without a quorum
- 13 Nov 2018quorum not met
Stakeholders Relationship Committee
Chair Hiten M Parikh
Vimal Dhirendra Shah, Jayanti Chandrasekar
1 meeting of 1 without a quorum
- 13 Nov 2018quorum not met
Corporate Social Responsibility Committee
Chair Navnit Jethabhai Patel
Vimal Dhirendra Shah, Sanjivkumar Shah
No meeting listed in the filing.
Other Committee
Chair Sanjivkumar Shah
Hiten M Parikh, Jayanti Chandrasekar, Shaik Amanullah Mohamed Azmathullah
1 meeting of 1 without a quorum
- 13 Nov 2018quorum not met
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Bahedia and AssociatesPeer-review certificate valid to Feb 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Norris Medicines AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Norris Medicines share news and announcements
Annual general meeting, 29 Sep 2026
25,799 shareholders on the register on 22 Sep 2026; present: 1 promoter and 39 others; votes counted by HEMANT SHRIPAD SHETYE / HSPN AND ASSOCIATES LLP.The company's voting result (opens in a new tab)
- To receive, consider and adopt the Audited Financial Statements of the Company for the year ended 31st March, 2026 together with Reports of Board of Directors and Auditors thereon.Ordinary99.59% for0.41% against
Against: promoters 0.00% · institutions 0.00% · other public 0.63%
Turnout: all 67.40% · promoters 69.44% · institutions 0.00% · other public 66.42%
- To appoint a Director in place of Mr. Praveen J. Bafna, (DIN No. 06538685), who retires by rotation and being eligible, offers himself for re-appointment.Ordinary99.59% for0.41% against
Against: promoters 0.00% · institutions 0.00% · other public 0.63%
Turnout: all 67.40% · promoters 69.44% · institutions 0.00% · other public 66.42%
- Appointment of Mr. Vimal D. Shah (Din: 01506655) As A Managing Director of the Company.SpecialPromoters have an interest in it99.37% for0.63% against
Against: promoters 0.00% · institutions 0.00% · other public 0.63%
Turnout: all 43.80% · promoters 0.04% · institutions 0.00% · other public 66.42%
- Increase in the limits of borrowing authorized by the company.Special99.59% for0.41% against
Against: promoters 0.00% · institutions 0.00% · other public 0.63%
Turnout: all 67.40% · promoters 69.44% · institutions 0.00% · other public 66.42%
- Authorization for sale, lease, or disposal of the whole or substantially the whole of the company's undertaking by the Company.Special99.59% for0.41% against
Against: promoters 0.00% · institutions 0.00% · other public 0.63%
Turnout: all 67.40% · promoters 69.44% · institutions 0.00% · other public 66.42%
- Enhancement of the existing limit under Section 186 of the Companies Act, 2013.Special99.59% for0.41% against
Against: promoters 0.00% · institutions 0.00% · other public 0.63%
Turnout: all 67.40% · promoters 69.44% · institutions 0.00% · other public 66.42%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Compliance
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
The company's own answers in its filing.